HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 47,000
+4,550 (10.72%)
At close: Jun 12, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 337.28 billion as of June 12, 2026. Its market cap has increased by 122.74% in one year.
Market Cap
337.28B
Enterprise Value
344.53B
Revenue
14.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
47,000.00
Market Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 337.28B, an increase of 195.40%. That is a compound annual growth rate of 96.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 337.28B | 2.99% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 750.33B |
| ImmuneOncia Therapeutics | 381.06B |
| Samyang Biopharm | 377.74B |
| NOVAREX | 249.09B |
| Vivozon Pharmaceutical | 243.37B |
| CellBion | 236.30B |
| DAE HWA Pharmaceutical | 182.35B |
| High Tech Pharm | 148.76B |